Amylases, nucleic acids encoding them and methods for making and using them
US-9249400-B2 · Feb 2, 2016 · US
US2020131491A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020131491-A1 |
| Application number | US-201816603639-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 10, 2018 |
| Priority date | Apr 11, 2017 |
| Publication date | Apr 30, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to glucoamylase variants having an increase in raw starch activity compared to the guy-coamylase disclosed as SEQ ID NO: 2, comprising one or more modifications in the catalytic domain and/or one or more modifications in the starch binding domain selected from: a) at least one, preferably at least two, preferably at least three, preferably at least four of: V18M, T43K, N112L, T116R, A117Q, G120S, A271F, Y295W, Q318Y; and/or b) Introducing at least three, preferably at least four substitutions selected from the group: S458C, S458SCGG, S458SGGC, A493V, A518K, E520Q, N527M, S540K, R, S(G)546P, T(V)549W, N503R, N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Opening claim text (preview).
1 . A glucoamylase variant, having increased raw starch hydrolytic activity at pH=4.0, T=32° C., compared to the glucoamylase disclosed in SEQ ID NO: 2, wherein the variant is derived from a glucoamylase having a catalytic domain comprising amino acids 1-454 of SEQ ID NO: 2 or 1-454 of SEQ ID NO: 4, a linker comprising amino acids 455-462 of SEQ ID NO: 2 or amino acids 455-465 of SEQ ID NO: 4 and a starch binding domain comprising amino acids 463-556 of SEQ ID NO: 2 or amino acids 466-559 of SEQ ID NO: 4, and wherein the variant further comprises a substitution at one or more positions selected from the group consisting of: V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; S95P+A121P+Y295W+T116R+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+G120S+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+T116R+A121P+Q318Y+S458SCGG+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M+T(V)549W+N503R; V18M+T43K+S95P+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+Q318Y+S95P+A121P+Y295W+S458SCGG+N527M+T(V)549W; S95P+A121P+Y295W+G120S+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M T(V)549W; S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; S95P+T116R+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W+N503R; S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+A518K+N527M+T549W; T43K+S95P+G120S+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; S95P+G120S+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+Y295W+A518K+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; T43K+S95P+A121P+Q318Y+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+N527M+T549W; S95P+A121P+Y295W+T116R+N527M+T(V)549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A493V+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; S95P+A121P+Y295W+A117Q+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+N527M+T549W; T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; S95P+T116R+A121P+Y295W+A518K+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T(V)549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A518K+T549W; S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; S95P+G120S+A121P+Y295W+N527M+T(V)549W; S95P+A121P+Y295W+A518K+N527M+T(V)549W; S95P+A121P+Y295W+N527M+T(V)549W; S95P+N112L+A121P+Y295W+N527M+T(V)549W; S95P+A121P+Y295W+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+N527M+T549W; S95P+G120S+A121P+Y295W+A518K+N527M+T(V)549W; S95P+N112L+A121P+Y295W+A518K+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T549W; S95P+A121P+Y295W+A493V+A518K+E520Q+T549W; S95P+A121P+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+A518K+T(V)549W; S95P+A121P+Y295W+A518K+N527M; S95P+A121P+Y295W+S458C+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; S95P+A121P+Y295W+N527M+T549W; S95P+A121P+A271F+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+A493V; S95P+A121P+Y295W+S540K; S95P+A121P+Y295W+S540R; S95P+A121P+Y295W+A518K+N527M; S95P+A121P+Y295W+S458SGGC+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+N527M+T(V)549W; and S95P+A121P+Y295W+S458SCGG+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; wherein the position numbering corresponds to amino acid positions in the amino acid sequence set forth in SEQ ID NO: 2; and wherein the variants have at least 85%, but less than 100%, sequence identity to the amino acid sequence of SEQ ID NO: 2. 2 . The glucoamylase variant of claim 1 , wherein the variant is derived from a glucoamylase having a catalytic domain comprising amino acids 1-454 of SEQ ID NO: 2, a linker comprising amino acids 455-465 of SEQ ID NO: 4 and a starch binding domain comprising amino acids 466-559 of SEQ ID NO: 4, and wherein the variant comprises a combination of specific substitutions selected from the group consisting of: V18M+T43K+S95P+T116R+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; S95P+A121P+Y295W+T116R+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+G120S+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; V18M+T43K+S95P+T116R+A121P+Q318Y+S458SCGG+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M+T(V)549W+N503R; V18M+T43K+S95P+A121P+Q318Y+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+S458SCGG+N527M+T(V)549W; S95P+A121P+Y295W+G120S+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; V18M+T43K+S95P+A121P+Q318Y+S458SCGG+N527M T(V)549W; S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546PCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; S95P+T116R+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W+N503R; and S95P+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; and wherein the increase in raw starch hydrolytic activity compared to SEQ ID NO: 2 is at least 30%. 3 . The glucoamylase variant of claim 1 , wherein the variant is derived from the glucoamylase of SEQ ID NO: 2, and wherein the variant comprises a combination of specific substitutions selected from the group consisting of: V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+A121P+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; V18M+T43K+S95P+A121P+Y295W+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A493V+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A493V+A518K+N527M+T549W; T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+N527M+T549W; T43K+S95P+A121P+Q318Y+A493V+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T549W; V18M+T43K+S95P+T116R+A121P+Q318Y+A518K+T549W; V18M+T43K+S95P+A121P+Q318Y+A518K+N527M+T549W; T43K+S95P+A121P+Y295W+Q318Y+N527M+T549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T549W; S95P+A121P+Y295W+A493V+A518K+E520Q+T549W; S95P+A121P+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+N527M+T549W; S95P+A121P+A271F+Y295W+A518K+N527M+T549W; S95P+A121P+Y295W+A493V; S95P+A121P+Y295W+S540K; S95P+A121P+Y295W+S540R; and S95P+A121P+Y295W+A518K+N527M; and wherein the increase in raw starch hydrolytic activity compared to SEQ ID NO: 2 is at least 5%. 4 . The glucoamylase variant of claim 1 , wherein the variant is derived from a glucoamylase having a catalytic domain comprising amino acids 1-454 of SEQ ID NO: 2, a linker comprising amino acids 455-465 of SEQ ID NO: 4 and a starch binding domain comprising amino acids 466-559 of SEQ ID NO: 4, and wherein the variant comprises a substitution at one or more positions selected from the group consisting of: T43K+S95P+G120S+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; S95P+G120S+A121P+Y295W+N539R+I541Y+T543V+A545S+S546GCGV+G547S+S548T+T549A; T43K+S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; S95P+A121P+Y295W+T116R+N527M+T(V)549W; T43K+S95P+A121P+Y295W+Q318Y+A518K+N527M+T(V)549W; S95P+A121P+Y295W+A117Q+N527M+T(V)549W; S95P+T116R+A121P+Y295W+A518K+N527M+T(V)549W; V18M+T43K+S95P+A121P+Q318Y+A518K+T(V)549W; S95P+A121P+Y295W+Q318Y+N527M+T(V)549W; S
produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title
Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title
Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title
Biofuels, e.g. bio-diesel · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.